The Outcomes Research Consortium seeks to understand the end results of particular health care practices and interventions. End results include effects that people experience and care about, such as change in the ability to function. In particular, for individuals with chronic conditions—where cure is not always possible—end results include quality of life as well as mortality. By linking the care people get to the outcomes they experience, outcomes research has become the key to developing better ways to monitor and improve the quality of care.
We actively collaborate with corporate partners to evaluate new devices and pharmaceuticals. The Consortium maintains close relationships with numerous corporations that sponsor clinical trials, and has conducted hundreds of sponsored trials in the last decade. The Outcomes Research Consortium enjoys a justified reputation for swiftly and competently completing projects. We are often the top enrolling site. We have certified regulatory staff and meet or exceed all “Good Clinical Practice” standards; we routinely provide data supporting FDA submissions. Members of the Outcomes Research Consortium have individual appointments at more than 50 university hospitals. One advantage of this large consortium is that we have access to every surgical, critical care, and chronic pain populations, as well as patients in many other medical environments. Consequently, we can rapidly initiate and complete research protocols. Our primary goal, however, continues to be facilitating scientific exchange and collaboration.
The Consortium works with sponsors to initiate proposed studies as quickly as possible. We excel at providing the rapid study initiation times that sponsors now expect. We have considerable experience with “high-efficiency” research and sufficient staffing to routinely perform numerous study-related tasks simultaneously.